Asr LLC

1. GlaxoSmithKline, LLC. $946,697 395 payments
2. Pfizer Inc. $550,054 138 payments
3. AbbVie, Inc. $289,096 71 payments
4. Evofem Biosciences, Inc. $150,433 35 payments
5. Sumitomo Pharma America, Inc. $25,427 13 payments
6. AstraZeneca Pharmaceuticals LP $9,401 1 payment
7. Galderma Laboratories, L.P. $3,917 1 payment

1. A Phase 3 Randomized Doubleblinded Placebocontrolled Trial to Evaluate the Efficacy and Safety of A Respiratory Syncytial Virus RSV Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated During Pregnancy $325,780 59 payments
2. Study name not reported $225,690 108 payments
3. A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Countr $219,836 109 payments
4. Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the $176,319 52 payments
5. A Phase 2 Placebocontrolled Randomized Proof of Concept Study of A Respiratory Syncytial Virus RSV Vaccine in Pregnant Women $91,996 21 payments
6. Menb Rec 2Nd Gen-023 (V72_57) $85,581 39 payments
7. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) $84,331 19 payments
8. Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsulesx2FTablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain $76,248 10 payments
9. Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent $76,075 43 payments
10. Study of Oral Elagolix Tablets in Combination With Combined Oral Contraceptive Capsules Tablets to Assess Dysmenorrhea Response in Adult Female Participants With Endometriosis and Associated Moderate to Severe Pain $68,580 18 payments

1. Professional salary support $124,446 32 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.